Italy · Delayed Price · Currency is EUR Merck & Co. Statistics
Total Valuation
Merck & Co. has a market cap or net worth of EUR 186.20 billion. The enterprise value is 209.47 billion.
| Market Cap | 186.20B |
| Enterprise Value | 209.47B |
Important Dates
The last earnings date was Thursday, October 30, 2025.
| Earnings Date | Oct 30, 2025 |
| Ex-Dividend Date | Sep 12, 2025 |
Share Statistics
| Current Share Class | 2.50B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.91% |
| Shares Change (QoQ) | -0.60% |
| Owned by Insiders (%) | 0.05% |
| Owned by Institutions (%) | 80.15% |
| Float | 2.49B |
Valuation Ratios
The trailing PE ratio is 11.48 and the forward PE ratio is 9.44.
| PE Ratio | 11.48 |
| Forward PE | 9.44 |
| PS Ratio | 3.40 |
| PB Ratio | 4.45 |
| P/TBV Ratio | 17.89 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 12.91 |
| EV / Sales | 3.76 |
| EV / EBITDA | 7.58 |
| EV / EBIT | 8.87 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.72 |
| Debt / EBITDA | 1.11 |
| Debt / FCF | n/a |
| Interest Coverage | 21.38 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 20.37% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 739,831 |
| Profits Per Employee | 219,225 |
| Employee Count | 75,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Merck & Co. has paid 2.36 billion in taxes.
| Income Tax | 2.36B |
| Effective Tax Rate | 12.71% |
Stock Price Statistics
The stock price has decreased by -22.80% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -22.80% |
| 50-Day Moving Average | 72.42 |
| 200-Day Moving Average | 74.91 |
| Relative Strength Index (RSI) | 50.56 |
| Average Volume (20 Days) | 224 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.27 |
Income Statement
In the last 12 months, Merck & Co. had revenue of EUR 54.75 billion and earned 16.22 billion in profits. Earnings per share was 6.44.
| Revenue | 54.75B |
| Gross Profit | 42.71B |
| Operating Income | 23.21B |
| Pretax Income | 18.59B |
| Net Income | 16.22B |
| EBITDA | 26.88B |
| EBIT | 23.21B |
| Earnings Per Share (EPS) | 6.44 |
Balance Sheet
The company has 7.35 billion in cash and 30.17 billion in debt, giving a net cash position of -22.82 billion.
| Cash & Cash Equivalents | 7.35B |
| Total Debt | 30.17B |
| Net Cash | -22.82B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 41.81B |
| Book Value Per Share | 16.68 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 78.02%, with operating and profit margins of 42.40% and 29.63%.
| Gross Margin | 78.02% |
| Operating Margin | 42.40% |
| Pretax Margin | 33.96% |
| Profit Margin | 29.63% |
| EBITDA Margin | 49.10% |
| EBIT Margin | 42.40% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 2.21, which amounts to a dividend yield of 2.99%.
| Dividend Per Share | 2.21 |
| Dividend Yield | 2.99% |
| Dividend Growth (YoY) | -22.00% |
| Years of Dividend Growth | 4 |
| Payout Ratio | n/a |
| Buyback Yield | 0.91% |
| Shareholder Yield | 3.91% |
| Earnings Yield | 8.71% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |